Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient

Andrea Montesel1, Claudio Bucolo2, Victoria Mouvet1

  • 1Department of Ophthalmology, Fondation Asile des Aveugles, Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.

Frontiers in Pharmacology
|January 11, 2021
PubMed

Insights

Severe COVID-19 may increase the risk of central retinal artery occlusion (CRAO). Ophthalmological surveillance is advised for COVID-19 patients to prevent vision loss from CRAO.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Infectious Diseases

Background:

  • COVID-19 is linked to inflammatory changes, endothelial dysfunction, and a procoagulant state.
  • The risk of thromboembolic complications in COVID-19 patients remains unclear.
  • Retinal artery occlusions result from multifactorial processes including inflammation and hypercoagulation.

Observation:

  • A case of central retinal artery occlusion (CRAO) occurred in a patient with a history of severe COVID-19.
  • This suggests a potential association between severe COVID-19 and retinal vascular events.

Findings:

  • COVID-19 may contribute to a hypercoagulable state, increasing the risk of retinal vascular occlusions.
  • Inflammation and hypercoagulation are known risk factors for retinal artery occlusions.

Implications:

  • COVID-19 patients may be at increased risk for retinal vascular occlusions.
  • Focused ophthalmological surveillance is recommended for early detection and management of CRAO in COVID-19 survivors.
  • Preventing vision loss from CRAO is crucial for managing healthcare system impact.

Related Concept Videos